OMOP Concept 37558746
Bortezomib and Bevacizumab-maly
StandardRegimenHemOnc127577Regimen
Maps from
0
Descendants
0
Valid from
17 Nov 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(25)Roll up to these when you need a wider cohort.
- 1Anti-VEGFR antibody-containing regimen
- 1bevacizumab
- 1Bevacizumab-maly-containing regimen
- 1bortezomib
- 1Bortezomib-containing regimen
- 1Multiagent regimen
- 1Proteasome inhibitor-containing regimen
- 1Synthetic regimen
- 1Targeted therapy
- 1Targeted therapy-containing regimen
- 2Anti-VEGF antibody
- 2Biosimilar
- 2Generic class-based regimen
- 2Irritant
- 2Light-chain (AL) amyloidosis medication
- 2Named class-based regimen
- 2Neutral
- 2Proteasome inhibitor
- 2WHO Essential Cancer Medicine
- 3Antineoplastic monoclonal antibody
- 3Drugs by local effect
- 3Targeted therapeutic
- 3WHO Essential Medicine
- 4Antibody medication
- 4Antineoplastics by class effect
Get this concept via the API
Resolve Bortezomib and Bevacizumab-maly - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/37558746?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card